EQUITY ALERT: The Rosen Law Firm Reminds Cellular Biomedicine Group Inc. Investors of the Important Deadline in the Class Act...
May 11 2015 - 5:13PM
Business Wire
The Rosen Law Firm, a global investor rights firm, reminds
purchasers of Cellular Biomedicine Group Inc. (NASDAQ:CBMG)
securities from June 18, 2014 through April 7, 2015 of the
important June 22, 2015 lead plaintiff deadline in the class action
lawsuit. The lawsuit seeks to recover damages for Cellular
Biomedicine investors under the federal securities laws.
To join the Cellular Biomedicine class action, go to the firm’s
website at http://www.rosenlegal.com/cases-569.html or call Phillip
Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email
pkim@rosenlegal.com or kchan@rosenlegal.com for information on the
class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The lawsuit alleges that the Company made false and/or
misleading statements and/or failed to disclose that: (1) the
Company used paid stock promoter to achieve its unsustainable $500m
valuation, but failed to disclose such use in its regulatory
filings; (2) the Company’s “Car-T” technology experienced patient
deaths and lacked any meaningful market value; and (3) as a result
of the above, the Company’s financial statements were materially
false and misleading at all relevant times. When the true details
entered the market, the suit claims that investors suffered
damages.
If you wish to join the class action and recover your losses, go
to the firm’s website at http://www.rosenlegal.com/cases-569.html
or to discuss your rights or interests regarding this class action,
please contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen
Law Firm toll free at 866-767-3653 or via e-mail at
pkim@rosenlegal.com or kchan@rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
The Rosen Law Firm, P.A.Laurence Rosen, Esq.Phillip Kim,
Esq.Kevin Chan, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212)
202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Sep 2023 to Sep 2024
